A survey investigating health-related quality of life in adolescents with moyamoya disease

ISRCTN ISRCTN24696854
DOI https://doi.org/10.1186/ISRCTN24696854
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number SHAM123, NRF-2019R1AC1004633
Sponsor Yonsei University
Funder National Research Foundation of Korea
Submission date
09/12/2021
Registration date
09/12/2021
Last edited
20/12/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Moyamoya disease is a chronic (long-term) progressive (that gets worse with time) disease of the blood vessels of the brain (cerebrovascular) that requires regular monitoring to control the disease and its related complications. Moyamoya disease can lead to stroke or bleeding in the brain or stroke. It can also affect brain function and cause disability.

This study aims to investigate whether understanding of the disease, a sense of coherence and social support were significant factors contributing to lower stress, improved health, and quality of life in adolescents with moyamoya disease. This study aims to help health experts to develop a treatment strategy based on a health and wellbeing approach for chronic disease management.

Who can participate?
Adolescents who have had moyamoya disease for longer than one month with no other diseases.

What does the study involve?
Participants will complete questionnaires about social support, sense of coherence, stress, health behavior, health status, and quality of life on a single occasion.

What are the possible benefits and risks of participating?
The potential benefits to participants are that they might better understand the factors affecting their health-related quality of life with moyamoya disease and other chronic diseases.
There are no anticipated risks as this study is a survey.

Where is the study run from?
Yonsei University (Korea, South)

When is the study starting and how long is it expected to run for?
From November 2017 to October 2018

Who is funding the study?
National Research Foundation of Korea (NRF) (Korea, South)

Who is the main contact?
Prof Insun Yeom
ruthin76@yuhs.ac

Contact information

Prof Insun Yeom
Public

Jeunggaro 150
Seoul
03670
Korea, South

ORCiD logoORCID ID 0000-0001-9914-9486
Phone +82-10-9018-5666
Email ruthin76@yuhs.ac

Study information

Primary study designObservational
Study designCross sectional study
Secondary study designCross sectional study
Study type Participant information sheet
Scientific titleStructural equation model of health-related quality of life in adolescents with moyamoya disease: based on the salutogenesis theory
Study objectivesKnowledge of moyamoya disease, social support, and sense of coherence affect individual stress and health behaviors, in turn affecting subjective health status, depression, and quality of life
Ethics approval(s)Approved 11/07/2017, Severance Hospital Institutional Review Board (Yonsei University Health System, 50-1 Yeonse-ro, Seodaemun-gu, Seoul 03722, Korea; +82-02-2228-0450; irb@yuhs.ac)
Health condition(s) or problem(s) studiedAdolescents with Moyamoya disease
InterventionThe study involves a cross-sectional survey of Korean adolescents with Moyamoya disease. The study will examine a hypothetical model by integrating the concepts of a structural health-related quality-of-life model based on the salutogenesis theory among adolescents with moyamoya disease in Korea. Data on health-related quality of life of adolescents with moyamoya disease will be collected at a single timepoint using the following scales: social support rating scale, sense of coherence scale, stress scale, health behavior scale, subjective health status scale, and quality-of-life scale. A structural equation model will be used to analyze the data.
Intervention typeOther
Primary outcome measure(s)

1. Subjective health status measured using a 5-point simple-question Likert scale, ranging from 1 point (very bad) to 5 points (very good) at a single timepoint
2. Quality of life measured using a quality of life scale (Varni et al., 1998) at a single timepoint

Key secondary outcome measure(s)

1. Social support measured using a social support scale (Malecki et al., 2000) at a single timepoint. Higher scores indicate more social support in each area.
2. Sense of coherence measured using a sense of coherence scale (Antonovsky, 1987) at a single timepoint
3. Health behavior measured using the moyamoya health behavior scale (Oh et al., 2021) at a single timepoint. Higher scores indicate better health behaviors related to moyamoya disease.
4. Stress measured using the stress scale for adolescents (Kim and Bae, 2014) at a single timepoint

Completion date30/10/2018

Eligibility

Participant type(s)Patient
Age groupMixed
SexAll
Target sample size at registration230
Total final enrolment239
Key inclusion criteria1. Moyamoya disease for >1 month
2. No other diseases
3. Able to respond to a questionnaire.
4. Able to confirm their understanding of the purpose of the study and agree to participate voluntarily providing online written consent
5. Aged between 13 and 18 years
Key exclusion criteria1. History of mental illness
2. Difficulty in participating (e.g. hearing and visual impairment)
Date of first enrolment01/01/2018
Date of final enrolment30/10/2018

Locations

Countries of recruitment

  • Korea, South

Study participating centre

Yonsei University
Moyamoya Disease Clinic
Pediatric Neurosurgery
50-1 Yeonse-ro
Seodaemun-gu
Seoul
03722
Korea, South

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
IPD sharing planData will be made available upon request to Prof Won-oak Oh (wooh@korea.ac.kr)

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes

Editorial Notes

09/12/2021: Trial’s existence confirmed by Severance Hospital Institutional Review Board.